Immunocellular Therapeutics, Ltd. (IMUC) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Join SI Premium – FREE
Immunocellular Therapeutics, Ltd. (NYSE: IMUC) reported Q2 EPS of $0.04, $0.10 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Immunocellular Therapeutics, Ltd. (IMUC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nike (NKE) Tops Q1 EPS by 4c
- ESCO Technologies completes acquisition of Megger Group Limited
- onsemi cuts Synaptics deal price to $5.7B after rival bid
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
